Effect of Immunization with a Common Recall Antigen on Viral Expression in Patients Infected with Human Immunodeficiency Virus Type 1
Sharilyn K. Stanley, M.D., Mario A. Ostrowski, M.D., Jesse S. Justement, B.S., Kira Gantt, B.A., Susan Hedayati, B.S., Margaret Mannix, R.N., Kim Roche, R.N., Douglas J. Schwartzentruber, M.D., Cecil H. Fox, Ph.D., and Anthony S. Fauci, M.D.
Background Activation of the immune system is a normal responseto antigenic stimulation, and such activation enhances the replicationof human immunodeficiency virus type 1 (HIV-1). We studied theeffect of immunization with a common recall antigen on viralexpression in HIV-1infected patients, on the abilityto isolate virus, and on the susceptibility to HIV-1 infectionof peripheral-blood mononuclear cells (PBMCs) from control subjectsnot infected with HIV-1.
Methods Thirteen HIV-1infected patients and 10 uninfectedadults were given a 0.5-ml booster dose of tetanus toxoid. Studieswere performed to evaluate changes in the degree of plasma viremia,proviral burden, the ability to isolate HIV-1, and the susceptibilityof PBMCs to acute infection in vitro. Two patients underwentsequential lymph-node biopsies for the assessment of viral burdenin these tissues.
Results All 13 HIV-1infected patients had transient increasesin plasma viremia after immunization, and the proviral burdenincreased in 11. These changes did not correlate with the base-lineCD4+ T-cell counts. The lymph-node tissue also had increasesin the proviral burden and viral RNA after immunization. Thevirus was more easily isolated from PBMCs from nine of the patientsafter immunization than before immunization. Despite considerablevariability in the results, PBMCs from 7 of the 10 normal subjectswere more easily infected in vitro with HIV-1 after immunizationthan before immunization.
Conclusions Activation of the immune system by an ongoing antigen-specificimmune response to an exogenous stimulus transiently increasesthe expression of HIV-1 and may enhance the susceptibility ofuninfected subjects to HIV-1.
Source Information
From the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (S.K.S., M.A.O., J.S.J., K.G., S.H., K.R., A.S.F.); the Nursing Department, Warren Grant magnuson Clinical Center (M.M.); and the Division of Cancer Treatment, National Cancer Institute (D.J.S.) all at the National Institutes of Health, Bethesda, Md.; and Molecular Histology Inc., Gaithersburg, Md. (C.H.F.).
Address reprint requests to Dr. Stanley at the National Institutes of Health, Bldg. 30, Rm. 7A03, 31 Center Dr., MSC-2520, Bethesda, MD 20892-2520.
Barry, A. P., Silvestri, G., Safrit, J. T., Sumpter, B., Kozyr, N., McClure, H. M., Staprans, S. I., Feinberg, M. B.
(2007). Depletion of CD8+ Cells in Sooty Mangabey Monkeys Naturally Infected with Simian Immunodeficiency Virus Reveals Limited Role for Immune Control of Virus Replication in a Natural Host Species. J. Immunol.
178: 8002-8012
[Abstract][Full Text]
Gondois-Rey, F., Biancotto, A., Fernandez, M. A., Bettendroffer, L., Blazkova, J., Trejbalova, K., Pion, M., Hirsch, I.
(2006). R5 Variants of Human Immunodeficiency Virus Type 1 Preferentially Infect CD62L- CD4+ T Cells and Are Potentially Resistant to Nucleoside Reverse Transcriptase Inhibitors. J. Virol.
80: 854-865
[Abstract][Full Text]
Ajariyakhajorn, C., Mammen, M. P. Jr., Endy, T. P., Gettayacamin, M., Nisalak, A., Nimmannitya, S., Libraty, D. H.
(2005). Randomized, Placebo-Controlled Trial of Nonpegylated and Pegylated Forms of Recombinant Human Alpha Interferon 2a for Suppression of Dengue Virus Viremia in Rhesus Monkeys. Antimicrob. Agents Chemother.
49: 4508-4514
[Abstract][Full Text]
Sun, L., Abdelwahab, S. F., Lewis, G. K., Garzino-Demo, A.
(2004). Recall antigen activation induces prompt release of CCR5 ligands from PBMC: implication in memory responses and immunization. Int Immunol
16: 1623-1631
[Abstract][Full Text]
Equils, O., Shapiro, A., Madak, Z., Liu, C., Lu, D.
(2004). Human Immunodeficiency Virus Type 1 Protease Inhibitors Block Toll-Like Receptor 2 (TLR2)- and TLR4-Induced NF-{kappa}B Activation. Antimicrob. Agents Chemother.
48: 3905-3911
[Abstract][Full Text]
Richardson, J., Broche, S., Baud, S., Leste-Lasserre, T., Femenia, F., Levy, D., Moraillon, A., Pancino, G., Sonigo, P.
(2002). Lymphoid activation: a confounding factor in AIDS vaccine development?. J. Gen. Virol.
83: 2515-2521
[Abstract][Full Text]
Levine, A. M.
(2002). Evaluation and Management of HIV-Infected Women. ANN INTERN MED
136: 228-242
[Abstract][Full Text]
Lawn, S. D., Butera, S. T., Folks, T. M.
(2001). Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection. Clin. Microbiol. Rev.
14: 753-777
[Abstract][Full Text]
Mengozzi, M., Malipatlolla, M., De Rosa, S. C., Herzenberg, L. A., Herzenberg, L. A., Roederer, M.
(2001). Naive CD4 T cells inhibit CD28-costimulated R5 HIV replication in memory CD4 T cells. Proc. Natl. Acad. Sci. USA
10.1073/pnas.211205098v1
[Abstract][Full Text]
Chen, Z. W., Shen, Y., Zhou, D., Simon, M., Kou, Z., Lee-Parritz, D., Shen, L., Sehgal, P., Letvin, N. L.
(2001). In Vivo T-Lymphocyte Activation and Transient Reduction of Viral Replication in Macaques Infected with Simian Immunodeficiency Virus. J. Virol.
75: 4713-4720
[Abstract][Full Text]
Hogan, C. M., Hammer, S. M.
(2001). Host Determinants in HIV Infection and Disease: Part 2: Genetic Factors and Implications for Antiretroviral Therapeutics. ANN INTERN MED
134: 978-996
[Abstract][Full Text]
Scales, D., Ni, H., Shaheen, F., Capodici, J., Cannon, G., Weissman, D.
(2001). Nonproliferating Bystander CD4+ T Cells Lacking Activation Markers Support HIV Replication During Immune Activation. J. Immunol.
166: 6437-6443
[Abstract][Full Text]
Friedman, S. R., Kottiri, B. J., Neaigus, A., Curtis, R., Vermund, S. H., Des Jarlais, D. C.
(2000). Network-related Mechanisms May Help Explain Long-term HIV-1 Seroprevalence Levels That Remain High but Do Not Approach Population-Group Saturation. Am J Epidemiol
152: 913-922
[Abstract][Full Text]
Kilby, J. M., Goepfert, P. A., Miller, A. P., Gnann, J. W. Jr., Sillers, M., Saag, M. S., Bucy, R. P.
(2000). Recurrence of the Acute HIV Syndrome after Interruption of Antiretroviral Therapy in a Patient with Chronic HIV Infection: A Case Report. ANN INTERN MED
133: 435-438
[Abstract][Full Text]
Wiegers, G. J., Stec, I. E. M., Klinkert, W. E. F., Reul, J. M. H. M.
(2000). Glucocorticoids Regulate TCR-Induced Elevation of CD4: Functional Implications. J. Immunol.
164: 6213-6220
[Abstract][Full Text]
Campbell, T. B., Sevin, A., Coombs, R. W., Peterson, G. C., Rosandich, M., Kuritzkes, D. R., Mladenovic, J., Landay, A., Wong, R., Ambruso, D., Miles, S., Pomerantz, R. J., Schooley, R. T., the Adult AIDS Clinical Trials Group 285 Study Tea,
(2000). Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells. Blood
95: 48-55
[Abstract][Full Text]
Ferguson, N. M., deWolf, F., Ghani, A. C., Fraser, C., Donnelly, C. A., Reiss, P., Lange, J. M. A., Danner, S. A., Garnett, G. P., Goudsmit, J., Anderson, R. M.
(1999). Antigen-driven CD4+ T cell and HIV-1 dynamics: Residual viral replication under highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA
96: 15167-15172
[Abstract][Full Text]
Ohwada, A., Sekiya, M., Hanaki, H., Arai, K. K., Nagaoka, I., Hori, S., Tominaga, S., Hiramatsu, K., Fukuchi, Y.
(1999). DNA vaccination by mecA sequence evokes an antibacterial immune response against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother
44: 767-774
[Abstract][Full Text]
Severson, J. L., Tyring, S. K.
(1999). Relation Between Herpes Simplex Viruses and Human Immunodeficiency Virus Infections. Arch Dermatol
135: 1393-1397
[Abstract][Full Text]
Hanke, T., Samuel, R. V., Blanchard, T. J., Neumann, V. C., Allen, T. M., Boyson, J. E., Sharpe, S. A., Cook, N., Smith, G. L., Watkins, D. I., Cranage, M. P., McMichael, A. J.
(1999). Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen. J. Virol.
73: 7524-7532
[Abstract][Full Text]
Poss, M., Overbaugh, J.
(1999). Variants from the Diverse Virus Population Identified at Seroconversion of a Clade A Human Immunodeficiency Virus Type 1-Infected Woman Have Distinct Biological Properties. J. Virol.
73: 5255-5264
[Abstract][Full Text]
Moriuchi, H., Moriuchi, M., Fauci, A. S.
(1999). Induction of HIV-1 Replication by Allogeneic Stimulation. J. Immunol.
162: 7543-7548
[Abstract][Full Text]
Roubenoff, R., Skolnik, P. R., Shevitz, A., Snydman, L., Wang, A., Melanson, S., Gorbach, S.
(1999). Effect of a single bout of acute exercise on plasma human immunodeficiency virus RNA levels. J. Appl. Physiol.
86: 1197-1201
[Abstract][Full Text]
Zhou, D., Shen, Y., Chalifoux, L., Lee-Parritz, D., Simon, M., Sehgal, P. K., Zheng, L., Halloran, M., Chen, Z. W.
(1999). Mycobacterium bovis Bacille Calmette-Guerin Enhances Pathogenicity of Simian Immunodeficiency Virus Infection and Accelerates Progression to AIDS in Macaques: A Role of Persistent T cell Activation in AIDS Pathogenesis. J. Immunol.
162: 2204-2216
[Abstract][Full Text]
Wahl, S. M., Greenwell-Wild, T., Peng, G., Hale-Donze, H., Doherty, T. M., Mizel, D., Orenstein, J. M.
(1998). Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression. Proc. Natl. Acad. Sci. USA
95: 12574-12579
[Abstract][Full Text]
Ostrowski, M. A., Krakauer, D. C., Li, Y., Justement, S. J., Learn, G., Ehler, L. A., Stanley, S. K., Nowak, M., Fauci, A. S.
(1998). Effect of Immune Activation on the Dynamics of Human Immunodeficiency Virus Replication and on the Distribution of Viral Quasispecies. J. Virol.
72: 7772-7784
[Abstract][Full Text]
Ostrowski, M. A., Justement, S. J., Catanzaro, A., Hallahan, C. A., Ehler, L. A., Mizell, S. B., Kumar, P. N., Mican, J. A., Chun, T.-W., Fauci, A. S.
(1998). Expression of Chemokine Receptors CXCR4 and CCR5 in HIV-1-Infected and Uninfected Individuals. J. Immunol.
161: 3195-3201
[Abstract][Full Text]
Gelfand, J. M., Rudikoff, D., Lebwohl, M., Klotman, M. E.
(1998). Effect of UV-B Phototherapy on Plasma HIV Type 1 RNA Viral Level: A Self-controlled Prospective Study. Arch Dermatol
134: 940-945
[Abstract][Full Text]
Chun, T.-W., Engel, D., Mizell, S. B., Ehler, L. A., Fauci, A. S.
(1998). Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines. J. Exp. Med.
188: 83-91
[Abstract][Full Text]
Schacker, T., Ryncarz, A. J., Goddard, J., Diem, K., Shaughnessy, M., Corey, L.
(1998). Frequent Recovery of HIV-1 From Genital Herpes Simplex Virus Lesions in HIV-1-Infected Men. JAMA
280: 61-66
[Abstract][Full Text]
Grossman, Z., Feinberg, M. B., Paul, W. E.
(1998). Multiple modes of cellular activation and virus transmission in HIV infection: A role for chronically and latently infected cells in sustaining viral replication. Proc. Natl. Acad. Sci. USA
95: 6314-6319
[Abstract][Full Text]
Pirofski, L.-a., Casadevall, A.
(1998). Use of Licensed Vaccines for Active Immunization of the Immunocompromised Host. Clin. Microbiol. Rev.
11: 1-26
[Abstract][Full Text]
Kimata, J. T., Mozaffarian, A., Overbaugh, J.
(1998). A Lymph Node-Derived Cytopathic Simian Immunodeficiency Virus Mne Variant Replicates in Nonstimulated Peripheral Blood Mononuclear Cells. J. Virol.
72: 245-256
[Abstract][Full Text]
Chun, T.-W., Stuyver, L., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A., Fauci, A. S.
(1997). Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA
94: 13193-13197
[Abstract][Full Text]
Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Kalams, S. A., Walker, B. D.
(1997). Vigorous HIV-1-Specific CD4+ T Cell Responses Associated with Control of Viremia. Science
278: 1447-1450
[Abstract][Full Text]
Wu, L., Paxton, W. A., Kassam, N., Ruffing, N., Rottman, J. B., Sullivan, N., Choe, H., Sodroski, J., Newman, W., Koup, R. A., Mackay, C. R.
(1997). CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro. J. Exp. Med.
185: 1681-1692
[Abstract][Full Text]
Royce, R. A., Sena, A., Cates, W., Cohen, M. S.
(1997). Sexual Transmission of HIV. NEJM
336: 1072-1078
[Full Text]
Woods, T. C., Roberts, B. D., Butera, S. T., Folks, T. M.
(1997). Loss of Inducible Virus in CD45RA Naive Cells After Human Immunodeficiency Virus-1 Entry Accounts for Preferential Viral Replication in CD45RO Memory Cells. Blood
89: 1635-1641
[Abstract][Full Text]
Mulligan, K., Tai, V. W., Schambelan, M.
(1997). Energy Expenditure in Human Immunodeficiency Virus Infection. NEJM
336: 70-71
[Full Text]
Farber, C.-M., Barath, A. A., Dieye, T., Kroon, F. P., van Furth, R., Bruisten, S. M., Stanley, S. K., Ostrowski, M. A., Fauci, A. S.
(1996). The Effects of Immunization in Human Immunodeficiency Virus Type 1 Infection. NEJM
335: 817-819
[Full Text]
Greene, W. C.
(1996). Denying HIV Safe Haven. NEJM
334: 1264-1265
[Full Text]
Mengozzi, M., Malipatlolla, M., De Rosa, S. C., Herzenberg, L. A., Herzenberg, L. A., Roederer, M.
(2001). Naive CD4 T cells inhibit CD28-costimulated R5 HIV replication in memory CD4 T cells. Proc. Natl. Acad. Sci. USA
98: 11644-11649
[Abstract][Full Text]